SLActive_SBC_e_low - Your Soltution when bone is missing

Your solution when Bone is missing Straumann 速 SLActive & Straumann 速 BoneCeramic

uma

... o v e

nn 速 S LAc

so

r1

m

tive

ld!

Stra

illi on

i m pla

s nt

Optimal support in your daily practice

Straumann offers you pp High performance for challenging cases pp High confidence with GBR technique pp High success rate with Straumann® SLActive1

Straumann® SLActive Enhanced bone apposition2 Significantly more mature bone than with SLA®2

Straumann® BoneCeramic Designed for natural bone regeneration Large space for vital tissue formation

1

2

. Zöllner et al., Clin. Oral Impl. Res 19, 2008; 442 – 450 A T.O. Oates et al., Int J Oral Maxillofac Implants 2007; 22; 755 – 760 F. Schwarz et al., Bone regeneration in dehiscence-type defects at chemically modified (SLActive) and conventional SLA titanium implants: a pilot study in dogs. J Clin Periodontol 2007; 34; 78 – 86

1

Straumann ® SLActive – Optimal Activation of natural healing potential

Preclinical data indicates high healing potential

Straumann ® SLActive

pp Bone regeneration to the SLActive ® surface after 2 weeks2 pp Artificial dehiscence defect ­completely filled after 12 weeks2

New bone Week 2: 27 % BIC (p<0.001) Bone regeneration started around Straumann® SLActive

New bone Week 12: 80 % BIC (p<0.001) Defect completely filled

Straumann ® SLA

Artificial bone ­d efect Week 2: 0 % BIC

Significantly more mature bone than with ­Straumann® SLA

Week 12: 5 % BIC

BIC (%) 100

Straumann® SLA

Straumann® SLActive

*

80 60

Bone defect still present

Enhanced bone apposition in the early osseointegration stages3 pp Bone apposition significantly enhanced in the early ­osseointegration stages with ­Straumann® SLActive3 pp 60 % more bone (BIC) after 2 weeks with Straumann® SLActive compared to Straumann® SLA3 pp Earlier formation of more mature bone3

*

40 20 0 2 weeks

4 weeks

8 weeks

n=8

n=8

n=7

60 % more bone (BIC) on Straumann ® SLActive after 2 weeks (p<0.02)

3

2

60 % more bone (BIC) after 2 weeks with Straumann® ­SLActive

D. Buser et al., Enhanced bone apposition to a chemically modified SLA titanium surface in pigs.

J Dent Res. 2004; 83: 529 – 533

Straumann ® BoneCeramic – Designed to support natural bone healing

Composition of regenerated tissue 6 – 7 months post­augmentation in sinus % 100

Percentage of augmented area

90

26.6 %

37.7 %

80 70

58 %

Supports patient’s own bone regeneration

11 % more vital tissue and significantly less residual bone substitute with Straumann® BoneCeramic compared to bovine bone mineral, 6 – 7 months post-augmentation in sinus floor elevation4.

60 50

51.8 %

42.5 %

40 30 20

42 % 21.6 %

10

19.8 %

0 Native bone Bone substitute Non-mineralized tissue New mineralized bone

Straumann® BoneCeramic

Bovine bone mineral

Total vital tissue

Patient’s own bone regeneration

90 % porous structure pp Designed to facilitate cell migration into the hollow spaces pp Vast space for newly formed bone with a minimum amount of bone substitute material Large space for vital tissue formation Scanning electron micrograph illustrates the highly porous structure of a Straumann® BoneCeramic particle

4

Cordaro L, et al., Maxillary sinus grafting with Bio-Oss ® or Straumann ® Bone Ceramic: Histomorphometric results from a randomized controlled multicenter clinical trial. Clin Oral Impl Res 2008; 19: 796 – 803

3

Clinical case: Ridge preservation following tooth extraction for later implant placement

By Dr. Barry Levin, DMD Specialist in Periodontics and Implant Dentistry, Elkins Park PA Associate professor, Dept. of Periodontics, University of Pennsylvania/USA

4

Fig 1 – Fresh socket after extraction of mandibular molars. The immediate placement of implants is not indicated due to missing primary stability.

Fig 2 – Filling of the sockets with ­Straumann® BoneCeramic 500 – 1000.

Note: The yellow colour originates from the tetracycline added.

Fig 3 – Covering of the augmented site with a collagen membrane.

Fig 4 – Primary wound closure.

Fig 5 – After a healing period of 9 months the soft tissue is healed showing keratinized gingiva.

Fig 6 – Healed hard tissue at re-entry 9 months after augmentation.

Fig 7 – A biopsy was taken out of the augmented region.

Fig 8 – Straumann® implants with SLActive surface placed. Both implants are 4.8 mm x 10.0 mm wide neck; Standard Plus (WN; SP).

Fig 9 – Implants in situ.

Fig 10 – Wound closure.

Fig 11 – Radiographic picture reveals stable hard tissue situation 3 months post implantplacement and 12 months after grafting procedure.

Fig 12 – Histological specimen shows vast bone formation (pink colour) 9 months after augmentation and some residual Straumann® BoneCeramic particles (purple).

5

Straumann ® SLActive and Straumann ® BoneCeramic Ø 3.3 mm

Standard Implants

Ø 4.1 mm

Ø 4.8 mm

RN Ø 4.8 mm

RN Ø 4.8 mm

RN Ø 4.8 mm

WN Ø 6.5 mm

Ø 3.3 mm

Ø 4.1 mm

Ø 4.8 mm

Ø 4.8 mm

S Ø 3.3 RN

S Ø 4.1 RN

S Ø 4.8 RN

S Ø 4.8 WN

033.030S

033.230S

033.630S

2.8 mm

SLActive

®

–

6 mm 8 mm

033.131S

033.031S

033.231S

033.631S

10 mm

033.132S

033.032S

033.232S

033.632S 033.633S –

12 mm

033.133S

033.033S

033.233S

14 mm

033.134S

033.034S

16 mm

033.135S

033.035S

033.234S –

RN Ø 4.8 mm

RN Ø 4.8 mm

RN Ø 4.8 mm

Standard Plus Implants

NN Ø 3.5 mm

– WN Ø 6.5 mm

1.8 mm

SLActive ®

Ø 3.3 mm

Ø 3.3 mm

Ø 4.1 mm

Ø 4.8 mm

Ø 4.8 mm

SP Ø 3.3 NN

SP Ø 3.3 RN

SP Ø 4.1 RN

SP Ø 4.8 RN

SP Ø 4.8 WN 033.650S

6 mm

–

–

033.050S

033.250S

8 mm

033.951S

033.151S

033.051S

033.251S

033.651S

10 mm

033.952S

033.152S

033.052S

033.252S

033.652S 033.653S –

12 mm

033.953S

033.153S

033.053S

033.253S

14 mm

033.954S

033.154S

033.054S

033.254S

RN Ø 4.8 mm

RN Ø 4.8 mm

WN Ø 6.5 mm

Ø 3.3 mm

Ø 4.1 mm

Ø 4.8 mm

TE Ø 4.8 WN

Tapered Effect Implants 1.8 mm

SLActive

TE Ø 3.3 RN

TE Ø 4.1 RN

8 mm

033.721S

033.761S

–

10 mm

033.722S

033.762S

033.712S

®

12 mm

033.723S

033.763S

033.713S

14 mm

033.724S

033.764S

033.714S

NC Ø 3.3 mm

RC Ø 4.1 mm

RC Ø 4.8 mm

Bone Level Implants

6

Ø 3.3 mm

Ø 4.1 mm

Ø 4.8 mm

SLActive ®

BL Ø 3.3 NC

BL Ø 4.1 RC

BL Ø 4.8 RC

8 mm

021.2108

021.4108

021.6108

10 mm

021.2110

021.4110

021.6110

12 mm

021.2112

021.4112

021.6112

14 mm

021.2114

021.4114

021.6114

Straumann ® SLActive and Straumann ® BoneCeramic

Straumann ® BoneCeramic 070.203

Straumann ® BoneCeramic 400 – 700

Granule size: 400 – 700 microns Unit size: 0.25 g

070.204

Straumann ® BoneCeramic 500 – 1000

Granule size: 500 – 1000 microns Unit size: 0.5 g

070.205

Straumann ® BoneCeramic 500 – 1000

Granule size: 500 – 1000 microns Unit size: 1 g

S = Standard SP = Standard Plus TE = Tapered Effect BL = Bone Level NN = Narrow Neck Ø 3.5 mm RN = Regular Neck Ø 4.8 mm WN = Wide Neck Ø 6.5 mm NC = Narrow CrossFit™ RC = Regular CrossFit™

7

Notes

International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41 (0)61 965 11 11 Fax +41 (0)61 965 11 01 © Institut Straumann AG, 2009. All rights reserved.

Straumann ® and/or other trademarks and logos from Straumann ® that are mentioned herein are the trademarks or registered trademarks of Straumann Holding AG and/or its affiliates. All rights reserved.

Straumann products are CE marked 07/09

w w w.straumann.com